US-China biotech rivalry sparks calls for deeper discussion, says editor

The editor notes that the ongoing debate over the competitive relationship between U.S. and Chinese biotechnology sectors has been unfolding over recent months.

While many knowledgeable voices are contributing, the author feels the conversation has not yet addressed key issues in sufficient depth.

The piece invites readers to engage further, suggesting that a more thorough examination is needed as the rivalry continues to shape the industry.